Associate Professor of Surgery
Department of Surgery, Duke University Health System
Durham, North Carolina, United States
Dr. Michael Lidsky received his medical degree from Georgetown University in 2009 and completed his surgery residency at Duke University in 2016. He then completed subspecialty training in surgical oncology and hepatopancreatobiliary surgery at Memorial Sloan Kettering Cancer Center in 2018. Dr. Lidsky returned to Duke in 2018 as faculty and his clinical practice focuses on the surgical management of cancerous and pre-cancerous conditions of the liver, biliary tree, and pancreas. Dr. Lidsky leads the HAI team at Duke and he co-founded and co-leads the HAI Consortium Research Network (HCRN), a collaborative of over 300 surgeons and medical oncologists representing nearly 100 HAI centers internationally. Dr Lidsky is also the national study chair and site PI for several NIH-funded randomized trials. In addition to Dr. Lidsky’s clinical practice, his basic science and translational research explores functional genomic and molecular mechanisms of tumorigenesis and chemoresistance in primary and metastatic liver cancer.
P9. Discovery of novel genetic drivers of Cowden Syndrome using genome-wide CRISPR/Cas9 screening
Thursday, March 5, 2026
11:28 AM - 11:35 AM MST